ArticleViruses2026
First Identification of HEV Subtype 3i in Human Hepatitis E Cases in Central Italy.
Article in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
HEV genotype 3 is classified into several subtypes. In Italy, 3f, 3c, 3e and, rarely, 3a subtypes are usually detected in human hepatitis E cases: the present study documents, for the first time, the detection of the 3i subtype, previously described in Italy exclusively from wild boars. Routine surveillance by short Sanger sequences highlighted five hepatitis E cases with unusual HEV subtype between 2019 and 2023 in a small geographical area in Umbria, Central Italy. Further characterization of the whole HEV genome by NGS was successful in three of them. Through phylogenetic and p-distance analysis, all the sequences could be classified as subtype 3i, and three of them proved to be highly related to some strains observed in wild boars sampled in the same geographical area. The 3i subtype had never been detected previously in humans in Italy; it is likely that increased local circulation of 3i-like strains in wild boars may have increased the chance for their transmission to humans. Investigation of the possible risk factors for HEV infection highlighted consumption of raw/undercooked products from wild boars/pigs in three cases. However, in the remaining two cases, this source seems unlikely, and transmission might have occurred indirectly from contaminated sources, such as wastewater and home-grown vegetables. Further studies are needed to investigate if these latter sources may be more common than previously thought or may play a role in relation to specific HEV subtypes and/or only in rare and exceptional circumstances.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.